Contingency Management for Smoking Cessation

Overseen By Vinita Devarasetty, MPH

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Kansas Medical Center

Must be taking: Varenicline

Must not be taking: Smoking cessation medications

Disqualifiers: Pregnancy, Breastfeeding, Others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 12 weeks

20 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

Many hospitals and outpatient clinics often refer people who smoke to quitlines and provide prescriptions for smoking cessation medications, but patients rarely fully engage in counseling or use their cessation medications. This is a single-arm, open-label pilot study to provide feasibility metrics for a text-based contingency management (CM) intervention to increase engagement in smoking cessation treatment. All participants (N=20) will be referred to a state quitline and will receive a prescription for medication plus 12 weeks of a text-based CM intervention to increase engagement in quitline calls and varenicline utilization. The engagement of participants in quitline counseling will be tracked for 6 weeks and medication utilization for 12 weeks post-enrollment. The investigators will use mixed-methods to collect implementation and acceptability data to inform changes to the text-based contingency management (CM) intervention.

Are You a Good Fit for This Trial?

This trial is for Kansas residents who smoke at least one cigarette daily, can speak and read English, have a mobile phone that receives texts, are insured for varenicline (a smoking cessation medication), and don't have acute renal impairment or life-threatening illnesses. Participants must have smoked in the past 30 days.

Inclusion Criteria

I have smoked within the last 30 days.

I live in Kansas.

I have access to a mobile phone.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a text-based contingency management intervention to increase engagement in quitline calls and varenicline utilization

12 weeks

Text-based intervention

Follow-up

Participants are monitored for engagement in quitline calls and varenicline utilization

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• CounCM+MedCM (Health Rewards)

Trial Overview The study tests a text-based contingency management intervention designed to increase engagement with quitline counseling and use of varenicline. All participants will be referred to a state quitline, receive medication prescriptions, and undergo 12 weeks of the intervention.

How Is the Trial Designed?

Group I: MedCM plus CounsCM Experimental Treatment 1 Intervention

Mobile Contingency Management for counseling attendance and medication intake

Who Is Running the Clinical Trial?

University of Kansas Medical Center

Lead Sponsor

Trials

527

Recruited

181,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials

2,658

Recruited

3,409,000+

University of Oklahoma

Collaborator

Trials

484

Recruited

95,900+